Peripheral intake of the acetylcholinesterase antagonist physostigmine causes symptoms of anxiety and depression in humans by decreasing the breakdown of ACh and increasing levels of the neurotransmitter in the brain (52). The gene discussed is ACHE; the disease is major depressive disorder.